TY  - JOUR
AU  - Herrera-Martinez, Aura D
AU  - Hofland, Johannes
AU  - Hofland, Leo J
AU  - Brabander, Tessa
AU  - Eskens, Ferry A L M
AU  - Galvez Moreno, María A
AU  - Luque, Raúl M
AU  - Castaño, Justo P
AU  - de Herder, Wouter W
AU  - Feelders, Richard A
PY  - 2018
DO  - 10.1007/s40265-018-1033-0
UR  - http://hdl.handle.net/10668/13321
T2  - Drugs
AB  - Neuroendocrine tumors (NETs) originate from the neuroendocrine cell system in the bronchial and gastrointestinal tract and can produce hormones leading to distinct clinical syndromes. Systemic treatment of patients with unresectable NETs aims to...
LA  - en
PB  - Springer Link
KW  - Neuroendocrine tumors
KW  - Medical treatment
KW  - Treatment combinations
KW  - Targeted systemic treatment
KW  - Antineoplastic Agents
KW  - Combined Modality Therapy
KW  - Humans
KW  - Molecular Targeted Therapy
KW  - Neuroendocrine Tumors
KW  - Progression-Free Survival
KW  - Somatostatin
TI  - Targeted Systemic Treatment of Neuroendocrine Tumors: Current Options and Future Perspectives.
TY  - research article
VL  - 79
ER  -